Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the primary source of Colossal Biosciences' thylacine genome data by end of 2024?
Museum specimens • 25%
Fossilized remains • 25%
Genetic material from related species • 25%
Other • 25%
Scientific reports or publications detailing the source of genome data
Colossal's 99.9% Accurate Thylacine Genome Marks Breakthrough in Tasmanian Tiger De-Extinction Effort
Oct 16, 2024, 08:32 PM
A team of US and Australian researchers has made significant breakthroughs in efforts to bring the Tasmanian tiger (thylacine) back from extinction. They have successfully sequenced the thylacine genome with 99.9% accuracy, a world-first achievement described as '99.9% of the puzzle.' This progress was made possible by a 'putrid' specimen found in a museum cupboard. The de-extinction company Colossal Biosciences claims multiple scientific firsts in this endeavor. While scientists welcome the advancement, they express caution and wish to see the data supporting these claims.
View original story
Yes • 50%
No • 50%
PacBio sequencing • 25%
Nanopore sequencing • 25%
Illumina sequencing • 25%
Other • 25%
Yes • 50%
No • 50%
Elephant genome • 25%
Blue whale genome • 25%
Komodo dragon genome • 25%
Other • 25%
National Institutes of Health (NIH) • 25%
National Science Foundation (NSF) • 25%
European Research Council (ERC) • 25%
Other • 25%
New genetic adaptation • 25%
Disease resistance genes • 25%
Cold environment adaptations • 25%
Other • 25%
Saber-toothed tiger • 25%
Dodo bird • 25%
Megalodon • 25%
Other • 25%
Discovery of new regulatory mechanisms • 25%
Identification of new genome regions • 25%
New insights into evolutionary history • 25%
Other • 25%
Medical research • 25%
Environmental science • 25%
Evolutionary biology • 25%
Other • 25%
Cancer Research • 25%
Neurological Disorders • 25%
Genetic Disorders • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Genome editing accuracy • 25%
Public opposition or regulatory issues • 25%
Viability of living specimens • 25%
Embryo implantation success • 25%